๐ฐ Alkermes News
Page 15 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
December 14, 2023
The Alkermes Chief Executive said the deal would offer employees at the Monksland facility โan exciting opportunity for growth"
December 13, 2023
In this piece, we will take a look at the 12 best growth stocks to buy according to billionaire Ray Dalio’s Bridgewater Associates. If you want to see more stocks in this selection, then take a look at 5 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates. Since founding Bridgewater Associates […]
December 12, 2023
Alkermes (NASDAQ:ALKS – Get Free Report) issued an update on its FY 2023 earnings guidance on Monday morning. The company provided EPS guidance of 1.570-1.750 for the period, compared to the consensus EPS estimate of 1.590. The company issued revenue guidance of -. Alkermes Trading Up 0.9 % Shares of NASDAQ ALKS traded up $0.24 […]
December 11, 2023
NORTHAMPTON, MA / ACCESSWIRE / December 11, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportWe have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder - di...
December 9, 2023
Alkermes plc (NASDAQ:ALKS – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages […]
December 9, 2023
Shares of Alkermes plc (NASDAQ:ALKS – Get Free Report) have earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month […]
December 8, 2023
The Illuminate Hypersomnia initiative aims to highlight the lived experience of patients with idiopathic hypersomnia.ย
December 8, 2023
COGT | Complete Cogent Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
December 7, 2023
/PRNewswire/ -- The Sleep Consortium, in collaboration with sleep-related patient advocacy organizations worldwide, announces the Illuminate Hypersomnia...
December 7, 2023
The Sleep Consortium, in collaboration with sleep-related patient advocacy organizations worldwide, announces the Illuminate Hypersomnia initiative, a groundbreaking effort to highlight the lived experience of idiopathic hypersomnia (IH). This...